Last updated on November 2019

Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer


Find a site near you

Start Over

Research Site

Osaka-shi, Japan
5.13miles
  Connect »

Research Site

Osakasayama-shi, Japan
7.7miles
  Connect »